CIR
MRNA icon

Clear Investment Research’s Moderna MRNA Stock Holding History

Clear Investment Research’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.93K Buy
+97
New +$4.53K 0.01% 188
2025
Q4 		– Sell
-97
Closed -$2.51K – 166
2025
Q3 		$2.51K Hold
97
– – ﹤0.01% 214
2025
Q2 		$2.68K Buy
97
+29
+43% +$764 ﹤0.01% 191
2025
Q1 		$1.93K Buy
68
+29
+74% +$1.03K ﹤0.01% 192
2024
Q4 		$1.62K Hold
39
– – ﹤0.01% 195
2024
Q3 		$2.61K Buy
+39
New +$3.58K ﹤0.01% 186

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return